LevomequitazineAlternative Names: (-)-mequitazine; (S)-mequitazine; L-mequitazine; V0114; V0114CP
Latest Information Update: 14 May 2015
At a glance
- Originator Pierre Fabre
- Class Antiallergics; Phenothiazines; Sedating antihistamines; Small molecules
- Mechanism of Action Histamine H1 receptor antagonists; Muscarinic receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Perennial allergic rhinitis; Seasonal allergic rhinitis